The score is held back primarily by weak cash-flow conversion and volatile profitability despite a strong balance sheet. Valuation is supportive due to a low P/E and very high dividend yield, while technicals are mixed with modest positive momentum but the price still below longer-term moving averages.
Positive Factors
Strong balance sheet
A large equity base and low leverage provide durable financial flexibility: the company can support follow-on investments, absorb portfolio volatility, and avoid forced asset sales. This reduces financing risk over the next 2–6 months and supports strategic optionality.
Holding/investment platform model
Elron’s core model—building and holding stakes in technology and med‑tech companies—is structurally scalable and less capital‑intensive than manufacturing. Durable revenue sources derive from exits, fair‑value appreciation, and dividends, aligning incentives with long‑term portfolio value creation.
Episodes of strong profitability
A track record of high operating profitability in multiple years demonstrates the platform can generate outsized returns from successful portfolio outcomes. That capability supports long‑term value capture through exits and validates investment selection and governance playbooks.
Negative Factors
Poor cash conversion
Sustained negative operating and free cash flow erodes liquidity and forces reliance on asset sales or external financing to fund operations and investments. Over several months this raises the risk of constrained capital deployment and reduced ability to support portfolio companies.
Volatile profitability and revenue
Sharp swings from strong profits to sizable losses and a year with zero revenue indicate unstable underlying cash generation. This volatility undermines predictability of returns and complicates planning, making dividend or payout reliability and forecasting more uncertain.
Inconsistent returns on equity
Wide ROE swings suggest portfolio performance is uneven and outcomes depend heavily on timing of realizations. Inconsistent equity returns reduce confidence in steady shareholder value growth and make multi‑period performance harder to rely on for income or reinvestment planning.
Elron (ELRN) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪314.08M
Dividend Yield16.2%
Average Volume (3M)54.41K
Price to Earnings (P/E)9.7
Beta (1Y)1.04
Revenue GrowthN/A
EPS GrowthN/A
CountryIL
Employees8
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)67.70
Shares Outstanding53,378,853
10 Day Avg. Volume32,573
30 Day Avg. Volume54,408
Financial Highlights & Ratios
PEG Ratio-0.17
Price to Book (P/B)0.92
Price to Sales (P/S)0.00
P/FCF Ratio-41.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Elron Business Overview & Revenue Model
Company DescriptionElron Ventures Ltd formerly known as Elron Electronic Industries Ltd, is a venture capital firm specializing in early stage and seed investment. The firm prefers to invest in cybersecurity, enterprise software or healthcare industries. The firm prefers to invest in Israel sector. Elron Ventures Ltd was founded in 1962 and is based in Tel Aviv, Israel with additional office in New York, New York.
How the Company Makes MoneyElron primarily makes money through returns on its investment portfolio rather than through sales of products or services from its own operations. Its key sources of economic value are: (1) gains from exits—selling equity stakes in portfolio companies via mergers and acquisitions, secondary sales, or other liquidity events; (2) changes in fair value of its holdings, which can be recognized in financial results depending on accounting treatment of specific investments; and (3) income received from portfolio companies, such as dividends and interest, when applicable. Elron may also generate proceeds by participating in financing rounds (e.g., investing and later monetizing those positions) and by structuring investments through equity and/or convertible instruments. Specific significant partnerships or portfolio-company revenue contributions: null.
Elron Financial Statement Overview
Summary
Balance sheet strength and low leverage support financial stability, but profitability is volatile (including a sizable 2023 loss and 2025 showing zero revenue) and cash-flow quality is a major concern with consistently negative operating and free cash flow across 2020–2025.
Income Statement
58
Neutral
Profitability has been strong in several years (notably 2021–2024) with very high operating profitability, but results are volatile: 2023 swung to a sizable net loss, and 2025 shows zero revenue with operating losses despite positive net income (suggesting non-operating gains). Revenue growth is also unstable, including a sharp decline into 2025, which lowers confidence in the durability of earnings.
Balance Sheet
82
Very Positive
The balance sheet looks solid with a large equity base and modest leverage (debt-to-equity remains low in the years provided). Total assets and equity are sizable relative to debt, which provides flexibility and reduces financial risk. The main weakness is inconsistent returns on equity (strong in 2022 and 2024, negative in 2020 and 2023), reflecting uneven profitability rather than balance-sheet strain.
Cash Flow
34
Negative
Cash generation is a key weak spot: operating cash flow and free cash flow are negative every year shown (2020–2025), even in years with strong reported net income. Free cash flow trends are mixed and remain meaningfully below zero, indicating the business has not been consistently converting accounting profits into cash, which can pressure liquidity over time if sustained.
Breakdown
TTM
Dec 2025
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Income Statement
Total Revenue
41.86M
0.00
43.85M
16.09M
89.51M
37.82M
Gross Profit
41.86M
―
43.85M
16.09M
89.51M
37.82M
EBITDA
36.46M
-5.37M
38.01M
10.18M
81.96M
31.21M
Net Income
20.49M
10.07M
22.58M
-8.17M
69.52M
5.48M
Balance Sheet
Total Assets
128.69M
138.06M
147.31M
159.82M
169.56M
144.24M
Cash, Cash Equivalents and Short-Term Investments
69.73M
59.00M
64.36M
49.87M
53.34M
83.00M
Total Debt
7.16M
7.17M
10.30M
10.16M
10.71M
9.88M
Total Liabilities
13.15M
12.45M
22.08M
18.26M
17.90M
17.80M
Stockholders Equity
100.61M
104.81M
110.66M
129.01M
136.29M
100.27M
Cash Flow
Free Cash Flow
-2.97M
-2.30M
-3.87M
-3.54M
-5.53M
-5.23M
Operating Cash Flow
-2.96M
-2.28M
-3.86M
-3.54M
-5.53M
-5.19M
Investing Cash Flow
2.01M
22.70M
38.62M
13.47M
29.13M
-11.96M
Financing Cash Flow
-26.56M
-19.54M
-41.74M
-42.00K
-34.65M
41.46M
Elron Technical Analysis
Technical Analysis Sentiment
Positive
Last Price587.10
Price Trends
50DMA
505.27
Positive
100DMA
538.34
Negative
200DMA
549.42
Negative
Market Momentum
MACD
16.39
Negative
RSI
53.44
Neutral
STOCH
70.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:ELRN, the sentiment is Positive. The current price of 587.1 is above the 20-day moving average (MA) of 477.05, above the 50-day MA of 505.27, and above the 200-day MA of 549.42, indicating a neutral trend. The MACD of 16.39 indicates Negative momentum. The RSI at 53.44 is Neutral, neither overbought nor oversold. The STOCH value of 70.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:ELRN.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026